Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Metrics to compare | CYC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCYCPeersSector | |
---|---|---|---|---|
P/E Ratio | −17.4x | −2.6x | −0.6x | |
PEG Ratio | 0.57 | −0.08 | 0.00 | |
Price/Book | 3.4x | 3.1x | 2.6x | |
Price / LTM Sales | 6.7x | 2.8x | 3.2x | |
Upside (Analyst Target) | 91.1% | 12.0% | 48.9% | |
Fair Value Upside | Unlock | 6.3% | 7.2% | Unlock |